SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-04-22 10:06
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash
$-145,425
-5,817 vol
$25.00 each
0
Filed 2019-04-22 10:06
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash

-47,960 vol
0
Filed 2019-01-04
Tx date 2018-12-31
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,514 vol
5,817
Filed 2018-11-29
Tx date 2018-11-06
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+11,990 vol
47,960
Filed 2018-10-04
Tx date 2018-09-30
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,597 vol
4,303
Filed 2018-07-04
Tx date 2018-06-30
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,448 vol
2,706
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,258 vol
1,258
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,258 vol
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,258 vol
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,258 vol
1,258
Filed 2018-04-16
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
35,970
Filed 2017-08-22
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Bonita, David P.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
35,970